Clearside Biomedical (Germany) Today
CLM Stock | EUR 1.01 0.04 4.12% |
Performance3 of 100
| Odds Of DistressLess than 9
|
Clearside Biomedical is selling for under 1.01 as of the 1st of December 2024; that is 4.12% up since the beginning of the trading day. The stock's last reported lowest price was 1.01. Clearside Biomedical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Clearside Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of September 2024 and ending today, the 1st of December 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Clearside Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Clearside Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Clearside Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic Idea | Drugs (View all Themes) |
Business Concentration | Drugs (View all Sectors) |
Clearside Biomedical (CLM) is traded on Munich Exchange in Germany . The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clearside Biomedical's market, we take the total number of its shares issued and multiply it by Clearside Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Clearside Biomedical generates negative cash flow from operations
Check Clearside Biomedical Probability Of Bankruptcy
Clearside Biomedical Risk Profiles
Although Clearside Biomedical's alpha and beta are two of the key measurements used to evaluate Clearside Biomedical's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 2.88 | |||
Semi Deviation | 2.84 | |||
Standard Deviation | 4.58 | |||
Variance | 20.93 |
Clearside Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clearside Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Additional Tools for Clearside Stock Analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.